|
Companies
Presenting:
Aventis
AICPA
AT&T Corporation
Brown Raysman Millstein Felder & Steiner
Brody Berman Associates
Cargill
CPA North America LLC
Credit Suisse First Boston
Fish & Richardson
GE Commercial Finance
Goodwin Procter
IBM
I/C/M/B Ocean Tomo
Inflexion Point Strategy
Intecap
IP Innovations Financial Services
ipCapital Group, Inc.
Kenyon & Kenyon
Microsoft
Predictiv
Standard & Poors Corporate Value Consulting
Schulte Roth & Zabel
ThinkFire
Trenwith Valuation, LLC
UTEK Corporation
Benefits of
Attending:
Differentiate the valuation techniques of IP developed
internally versus acquired IP
Understand the proprietary of giving away IP to develop relationships
Learn how to minimize tax liabilities on IP
Gain insight into the merits of licensing IP from universities
Assess the risks of accusations of patent infringement
Listen to the dangers of trolls and countersuits
Determine when sharing know-how is an intelligent business
strategy
Ascertain when IP strategy can be designed to increase
market share
Learn when IP strategy can be implemented to achieve wide
profit margins
Determine the impact of taking reserves for IP infringement
Understand how your IP can disrupt a competitors
strategy
Gain insight in merits of a patent proliferation strategy
Assess the optimum R&D-to-patent yield ratio
Determine the merits of licensing exclusivity versus
non-exclusivity
Understand how intelligent management of IP adds to
enterprise value
Discern the risks of shareholder lawsuits for mismanaging IP |
Intellectual Property
is proving to be the primary driver of corporate earnings.
According to some experts, over 75% of the market valuation
of the S&P 500 is represented by intangible assets.
However not all patents are valuable and intellectual
property is often ill-managed.
Fewer than 3% of patents generate royalty income.
The Harvard Business Review reported that more than $1
trillion annually is wasted in patent assets. Failing to
harness the power of IP is equally as negligent as failing
to assign value to a companys IP portfolio. For instance:
Ernst & Young reports that patent licensing alone
should soar from the $110 billion it generated in revenue in
2000 to $500 billion by 2015.
Qualcomm has generated as much as $430 million in
licensing revenue in recent quarters while IBM has
consistently brought in between $1.5 and $2.0 billion
annually in licensing royalties.
Of course, mismanaging IP
may lead to loss of patents, allegations of patent
infringement and reserving enormous sums of money. For
instance:
Pfizer lost its patent for Viagra in China.
Brody Berman Associates estimates that the average cost
of patent litigation is $2.5 million.
Research in Motion has reserved $100 million in view of
its ongoing litigation.
Dont miss this unique opportunity to listen to world-renowned
authorities discuss a multitude of methods for deriving value from
intellectual assets. Be sure to hear the best strategies for insulating
your patent portfolio from legal challenges. Learn the ground-breaking
techniques for valuing an IP portfolio.
Intellectual Property is a Primary Driver of Corporate
Value and Corporate Americas Achilles Heel
Todays most powerful value driver of an enterprises growth lies in its
intellectual property portfolio. As Alan Greenspan said, "the economic
product of the United States has become predominantly conceptual."
The ability to introduce innovative products, to secure better
production methods, to become the sole provider of particular
merchandise all emanates from securing intellectual property rights.
Most institutional investors and corporate managers respect intellectual property as a legal construct. However, both
Wall Street and Corporate America have failed to appreciate the value
generatingability of IP. Thus, Corporate America has neglected to
actively manage its IP portfolio and professional investors have been
remiss in trying to assess the value of IP resident in the companies in
which they invest. Savvy business and portfolio managers are
beginning to appreciate the fact that IP is more than a legal claim on
ingenuity. IP is becoming a revenue producing asset, a crucial
ingredient in enhancing corporate brand equity and a weapon to
attack competitors. However, IP portfolios may be devalued by reverse
engineering and patent expirations. Also, asserting rights to IP is
often a necessary, albeit dangerous, proposition as such assertions
can boomerang in viscous countersuits.
Dont miss this unique opportunity to listen to leading IP professionals
discuss best practices for managing, defending and valuing
intellectual property.
REGISTER TODAY AND SAVE $500.
I look forward to meeting you in New York City on January 27-28.
David Wanetick
Managing Director
The Wall Street Transcript & Gateway Reports
Conference Chairman:
|